Researcher 20% (one year) at the Institute for Cancer Research, University of Oslo

Researcher 20% (one year) at the Institute for Cancer Research, University of Oslo

A part time position as scientist (20%) (one year) is open in the Experimental Cancer Immunotherapy Group led by Johanna Olweus, MD, PhD, at the Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet and Institute for Clinical Medicine, University of Oslo.

The project the scientist will be working on involves development of new T-cell based immunotherapies, specifically single-cell T-cell receptor sequencing, cloning and T-cell receptor synthesis, as well as analysis of sequencing data.

More about the position

Olweus is Head of the Dept. of Cancer Immunology at Oslo University Hospital Radiumhospitalet and leads a research group in the department and holds a position as Professor at the University of Oslo (UiO). The main focus of the Olweus group is to develop novel T-cell receptor-based cancer immunotherapies and new technologies for target and TCR identification, and to couple clinical immunotherapy trials with penetrating mechanistic analyses. The research is performed in an interdisciplinary and translational program. The research team is highly international and conducts research in close collaboration with world-leading international collaborators at institutions such as Netherlands Cancer Institute and Karolinska Institutet.

• Deep knowledge in T cell immunology and cancer immunology, including authorships on multiple scientific publications in these areas
• At least 5 years of relevant post-doctoral hands-on laboratory experience in molecular biology, specifically in immune receptor analysis (T-cell receptors or antibodies)
• Excellent written and spoken English
• Excellent team working skills

About the job

A part time position as scientist (20%) (one year) is open in the Experimental Cancer Immunotherapy Group led by Johanna Olweus, MD, PhD, at the Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet and Institute for Clinical Medicine, University of Oslo.

The project the scientist will be working on involves development of new T-cell based immunotherapies, specifically single-cell T-cell receptor sequencing, cloning and T-cell receptor synthesis, as well as analysis of sequencing data.

More about the position

Olweus is Head of the Dept. of Cancer Immunology at Oslo University Hospital Radiumhospitalet and leads a research group in the department and holds a position as Professor at the University of Oslo (UiO). The main focus of the Olweus group is to develop novel T-cell receptor-based cancer immunotherapies and new technologies for target and TCR identification, and to couple clinical immunotherapy trials with penetrating mechanistic analyses. The research is performed in an interdisciplinary and translational program. The research team is highly international and conducts research in close collaboration with world-leading international collaborators at institutions such as Netherlands Cancer Institute and Karolinska Institutet.

Qualifications requirements

Required selection criteria

Preferred skills

We offer

Read more about the benefits of working in the public sector at Employer Portal.

Inclusive worklife and diversity at UiO

Inclusion and diversity are a strength. The University of Oslo has a personnel policy objective of achieving a balanced gender composition. Furthermore, we want employees with diverse professional expertise, life experience and perspectives.

If there are qualified applicants with disabilities, employment gaps or immigrant background, we will invite at least one applicant from each of these categories to an interview.

We hope that you will apply for the position.

Application

Your application should include :

Application with attachments must be submitted via our recruitment system Jobbnorge, click "Apply for the position".

When applying for the position, we ask you to retrieve your education results from Vitnemålsportalen.no. If your education results are not available through Vitnemålsportalen, we ask you to upload copies of your transcripts or grades. Please note that all documentation must be in English or a Scandinavian language.

General information

The best qualified candidates will invited for interviews.

Applicant lists can be published in accordance with Norwegian Freedom of Information Act § 25. When you apply for a position with us, your name will appear on the public applicant list. It is possible to request to be excluded from this list. You must justify why you want an exemption from publication and we will then decide whether we can grant your request. If we cannot, you will hear from us.

Please refer to Rules for the use of research posts SKO 1108, 1109, 1110 and 1183 at UiO.

The University of Oslo has a transfer agreement with all employees that is intended to secure the rights to all research results etc.

The University of Oslo is Norway’s oldest and highest ranked educational and research institution, with 28 000 students and 7000 employees. The Institute of Clinical Medicine (Klinmed) is one of three institutes under the Faculty. Klinmed is responsible for the Faculty's educational and research activities at Oslo University Hospital and Akershus University Hospital. With about 800 employees spread over approximately 425 man-labour years, Klinmed is the university's largest institute. Our activities follow the clinical activity at the hospitals and are spread across a number of geographical areas.

#J-18808-Ljbffr